Skip to Main Content

Author Details

Jeanette Beers
and Blood Institute, National Institutes of Health
1996
51
17
PMIDPaper TitleJournal TitlePublished Year
36921440Corrigendum to "Human induced pluripotent stem cells generated from a patient with a homozygous mutation in the Lyn kinase gene" [Stem Cell Res. 64 (2022) 102933].Stem Cell Res2023
37890331Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene.Stem Cell Res2023
37883891Corrigendum to "iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II" [Exp. Cell Res. 412, Issue 1, 1 March 2022, 113007].Exp Cell Res2023
37610273A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction.Curr Protoc2023
37393720Three induced pluripotent stem cell lines (TRNDi033-A, TRNDi034-A, TRNDi035-A) generated from lymphoblasts of three apparently healthy individuals.Stem Cell Res2023
36921440Corrigendum to "Human induced pluripotent stem cells generated from a patient with a homozygous mutation in the Lyn kinase gene" [Stem Cell Res. 64 (2022) 102933].Stem Cell Res2023
37890331Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene.Stem Cell Res2023
37883891Corrigendum to "iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II" [Exp. Cell Res. 412, Issue 1, 1 March 2022, 113007].Exp Cell Res2023
37610273A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction.Curr Protoc2023
37393720Three induced pluripotent stem cell lines (TRNDi033-A, TRNDi034-A, TRNDi035-A) generated from lymphoblasts of three apparently healthy individuals.Stem Cell Res2023
34990619iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.Exp Cell Res2022
36215934Human induced pluripotent stem cells generated from a patient with a homozygous mutation in the Lyn kinase gene.Stem Cell Res2022
36070637Generation of human induced pluripotential stem cells from individuals with complex heterozygous, isogenic corrected, and homozygous Bloc1s1 mutations.Stem Cell Res2022
36399927Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene.Stem Cell Res2022
35660921Human induced pluripotent stem cells generated from Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome patients with a homozygous mutation in the PSMB8 gene (NIHTVBi016-A, NIHTVBi017-A, NIHTVBi018-A).Stem Cell Res2022
34990619iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.Exp Cell Res2022
35660921Human induced pluripotent stem cells generated from Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome patients with a homozygous mutation in the PSMB8 gene (NIHTVBi016-A, NIHTVBi017-A, NIHTVBi018-A).Stem Cell Res2022
36399927Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene.Stem Cell Res2022
36070637Generation of human induced pluripotential stem cells from individuals with complex heterozygous, isogenic corrected, and homozygous Bloc1s1 mutations.Stem Cell Res2022
36215934Human induced pluripotent stem cells generated from a patient with a homozygous mutation in the Lyn kinase gene.Stem Cell Res2022
34139597Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene.Stem Cell Res2021
34051448An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene.Stem Cell Res2021
34198154Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1.Stem Cell Res2021
34139597Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene.Stem Cell Res2021
34088014Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1.Stem Cell Res2021
34087995Generation of Alagille syndrome derived induced pluripotent stem cell line carrying heterozygous mutation in the JAGGED-1 gene at splicing site (Chr20: 10,629,709C>A) before exon 11.Stem Cell Res2021
34801429Corrigendum to "Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9" [Stem Cell Res. 56 (2021) 102554].Stem Cell Res2021
34619643Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9.Stem Cell Res2021
34801429Corrigendum to "Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9" [Stem Cell Res. 56 (2021) 102554].Stem Cell Res2021
34619643Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9.Stem Cell Res2021
34198154Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1.Stem Cell Res2021
34088014Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1.Stem Cell Res2021
34087995Generation of Alagille syndrome derived induced pluripotent stem cell line carrying heterozygous mutation in the JAGGED-1 gene at splicing site (Chr20: 10,629,709C>A) before exon 11.Stem Cell Res2021
34051448An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene.Stem Cell Res2021
32344328Generation of human induced pluripotent stem cells (NIHTVBi004-A, NIHTVBi005-A, NIHTVBi006-A, NIHTVBi007-A, NIHTVBi008-A) from 5 CADASIL patients with NOTCH3 mutation.Stem Cell Res2020
31968264Transcriptional Programming of Human Mechanosensory Neuron Subtypes from Pluripotent Stem Cells.Cell Rep2020
32114296An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182T>C) mutation in the NPC1 gene.Stem Cell Res2020
32344328Generation of human induced pluripotent stem cells (NIHTVBi004-A, NIHTVBi005-A, NIHTVBi006-A, NIHTVBi007-A, NIHTVBi008-A) from 5 CADASIL patients with NOTCH3 mutation.Stem Cell Res2020
31869686Generation of two tdTomato reporter induced pluripotent stem cell lines (NHLBIi003-A-1 and NHLBIi003-A-2) by AAVS1 safe harbor gene-editing.Stem Cell Res2020
33375166Modeling CNS Involvement in Pompe Disease Using Neural Stem Cells Generated from Patient-Derived Induced Pluripotent Stem Cells.Cells2020
33038742Four induced pluripotent stem cell lines (TRNDi021-C, TRNDi023-D, TRNDi024-D and TRNDi025-A) generated from fibroblasts of four healthy individuals.Stem Cell Res2020
31968264Transcriptional Programming of Human Mechanosensory Neuron Subtypes from Pluripotent Stem Cells.Cell Rep2020
31869686Generation of two tdTomato reporter induced pluripotent stem cell lines (NHLBIi003-A-1 and NHLBIi003-A-2) by AAVS1 safe harbor gene-editing.Stem Cell Res2020
33375166Modeling CNS Involvement in Pompe Disease Using Neural Stem Cells Generated from Patient-Derived Induced Pluripotent Stem Cells.Cells2020
33038742Four induced pluripotent stem cell lines (TRNDi021-C, TRNDi023-D, TRNDi024-D and TRNDi025-A) generated from fibroblasts of four healthy individuals.Stem Cell Res2020
32114296An induced pluripotent stem cell line (TRNDi001-D) from a Niemann-Pick disease type C1 (NPC1) patient carrying a homozygous p. I1061T (c. 3182T>C) mutation in the NPC1 gene.Stem Cell Res2020
30612078Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene.Stem Cell Res2019
31733441Generation of two induced pluripotent stem cell lines (NHLBIi001-A and NHLBIi001-B) from a healthy Caucasian female volunteer with normal cardiac function.Stem Cell Res2019
31710911Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system.Stem Cell Res2019
30640061Generation of an induced pluripotent stem cell line (TRNDi003-A) from a Noonan syndrome with multiple lentigines (NSML) patient carrying a p.Q510P mutation in the PTPN11 gene.Stem Cell Res2019
  • 1 - 50 of 102

Recommended Authors

The First Affiliated Hospital of Soochow University
Career Start Year 2009
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2008
Number of shared co-authors 0
Guangzhou University
Career Start Year 2007
Number of shared co-authors 1
Guangdong Medical University
Career Start Year 2006
Number of shared co-authors 0
Tokyo Metropolitan Institute of Medical Science, Japan Gladstone Institutes
Career Start Year 2006
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 2005
Number of shared co-authors 0
Stanford University
Career Start Year 2004
Number of shared co-authors 0
Catalan Institution for Research and Advanced Studies (ICREA)
Career Start Year 2004
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 2003
Number of shared co-authors 0
Chinese Academy of Sciences
Career Start Year 2003
Number of shared co-authors 0
BioMarin Pharmaceutical Inc.
Career Start Year 2003
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2002
Number of shared co-authors 3
Center for Biologics Evaluation and Research
Career Start Year 2002
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
College of Food Science and Technology, Nanjing Agricultural University
Career Start Year 1999
Number of shared co-authors 1
Department of Pediatrics/Rady Children's Hospital, University of California San Diego
Career Start Year 1999
Number of shared co-authors 0
Daegu Catholic University Medical Center, Catholic University of Daegu
Career Start Year 1999
Number of shared co-authors 0
Faculty of Medicine Siriraj Hospital, Mahidol University
Career Start Year 1998
Number of shared co-authors 0
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
The Institute for Cell Engineering, Johns Hopkins University
Career Start Year 1995
Number of shared co-authors 2
The Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center
Career Start Year 1994
Number of shared co-authors 1
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year 1994
Number of shared co-authors 1
Karolinska Institutet
Career Start Year 1994
Number of shared co-authors 0
RIKEN BioResource Research Center
Career Start Year 1992
Number of shared co-authors 0
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 1
Inc., Salk Institute for Biological Studies
Career Start Year 1989
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1989
Number of shared co-authors 3
Carpenter Group Consulting Inc., USA NxCell Inc., USA Q Therapeutics Inc.
Career Start Year 1988
Number of shared co-authors 1
Boston Children's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 3
Leiden University Medical Center
Career Start Year 1981
Number of shared co-authors 2

Collaborators

and Blood Institute, National Institutes of Health
Co-authored papers 38
and Blood Institute, National Institutes of Health
Co-authored papers 8
University of Macau
Co-authored papers 6
Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham
Co-authored papers 5
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Co-authored papers 2
Co-authored papers 2
Institute of Stem Cells and Regenerative Medicine (inStem)
Co-authored papers 2
Partners Healthcare Center for Personalized Genetic Medicine
Co-authored papers 1
Center for Precision Health Research, National Human Genome Research Institute
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
University of Southern California Keck School of Medicine
Co-authored papers 1
Royal Veterinary College
Co-authored papers 1
Center for Cancer Research National Cancer Institute, National Institutes of Health
Co-authored papers 1
Chalmers University of Technology
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
University of Michigan ann arbor
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Boston Children's Hospital, Harvard Medical School
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
McLean Hospital
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1